|Baseline characteristics of the coeliac disease study group|
|n = 700||n = 534 (76% )||n = 166 (24% )|
|Median age (range), years||49 (16–84)||48 (16–84)||53 (16–83)|
|Clinical presentation, %|
|Gastrointestinal symptoms and signs||70||70||70|
|Detected by screening*||21||22||18|
|Duration of symptoms|
|Median (range), years||3 (0–59)||3 (0–51)||2 (0–59)|
|OEGD at diagnosis, %||100||100||100|
|OEGD prior to diagnosis of CD, % *||21||19||27|
|Diagnosis was established in, %|
|Primary health care||52||55||42|
|Secondary health care||38||36||44|
|Tertiary health care||10||9||14|
CD coeliac disease.
* Screening performed because of patients belonged to a risk group (first-degree relatives of coeliac disease patients, those with type 1 diabetes mellitus, autoimmune thyroid disease, Sjögren’s syndrome and IgA deficiency).
† Other than the oesphago-gastroduodenoscopy by which the diagnosis of coeliac disease was confirmed.
Ukkola et al.
Ukkola et al. BMC Gastroenterology 2012 12:136 doi:10.1186/1471-230X-12-136